Catheter-based therapies for massive pulmonary embolism.

abstract：:There are a number of difficulties inherent in the analysis of such a large and diverse quantity of data. In a substantial number of clinical trials, there is no significant effort made to evaluate prosthetic performance as a function of preoperative cardiac anatomy. Hemodynamics have not been systematically studied i...

journal_title：Progress in cardiovascular diseases

authors： McClung JA,Stein JH,Ambrose JA,Herman MV,Reed GE

更新日期：1983-11-01 00:00:00

abstract：:Beta blockers have long been used in patients who have experienced a myocardial infarction. However, many new therapies are available for this patient group, and as a result, the current role of beta blockers may have become uncertain. In this article we address a series of questions related to the important and conti...

journal_title：Progress in cardiovascular diseases

authors： Freemantle N,Urdahl H,Eastaugh J,Hobbs FD

更新日期：2002-01-01 00:00:00

abstract：:The underlying causes of hypertensive disease remain unclear. This article has attempted to highlight potential dysfunctions in arterial pressure regulation which could either initiate or sustain the hypertensive process. As has been suggested innumerable times hypertension must certainly be a multifactorial abnormali...

journal_title：Progress in cardiovascular diseases

authors： Brody MJ,Zimmerman BG

更新日期：1976-03-01 00:00:00

abstract：OBJECTIVE:To perform a pilot evaluation of a pharmacist-led, multidisciplinary transitional care clinic for heart failure (HF) patients. BACKGROUND:Transitions of care in HF should include: medication reconciliation, multidisciplinary care, early post-discharge follow-up, and prompt intervention on HF signs and sympto...

journal_title：Progress in cardiovascular diseases

authors： Milfred-LaForest SK,Gee JA,Pugacz AM,Piña IL,Hoover DM,Wenzell RC,Felton A,Guttenberg E,Ortiz J

更新日期：2017-01-01 00:00:00

abstract：:Recent clinical studies performed in human subjects have provided important clues that improved our understanding of the mechanisms of atrial fibrillation (AF) and facilitated development of new treatment strategies. When analyzed together, these studies confirm the complexity and multifactorial nature of AF. Because ...

journal_title：Progress in cardiovascular diseases

authors： Oral H

更新日期：2005-07-01 00:00:00

abstract：:In heart failure (HF) management, noninvasive quantification of left ventricular (LV) function is rapidly evolving. Deformation parameters, such as strain, continue to challenge the central role of ejection fraction (EF) in diagnosis and prognostication of LV dysfunction in HF. The increasing recognition and use of de...

journal_title：Progress in cardiovascular diseases

authors： Harbo MB,Nordén ES,Narula J,Sjaastad I,Espe EKS

更新日期：2020-01-01 00:00:00

abstract：:Trastuzumab is the standard of care for the treatment of patients with ERB2-positive breast cancer. In a minority of patients, trastuzumab is associated with an increased incidence of cardiac dysfunction that ranges from asymptomatic decreases in left ventricular ejection fraction to symptomatic heart failure. In tria...

journal_title：Progress in cardiovascular diseases

authors： Carver JR

更新日期：2010-09-01 00:00:00

abstract：:Echocardiography is a valuable technique for the diagnosis and serial follow-up of patients with impaired cardiac function. It is subject to certain limitations due to the assumptions inherent in deriving ventricular volume from a one-dimensional measurement and must be interpreted with caution in cases of suspected r...

journal_title：Progress in cardiovascular diseases

authors： Mason SJ,Fortuin NJ

更新日期：1978-09-01 00:00:00

abstract：:In our increasingly cost-conscious health system, patients, clinicians, hospitals, and payers all agree about the urgent need to rein in runaway healthcare costs. High pharmaceutical costs make drugs unaffordable to many patients who may benefit from them, including some insured patients who face prohibitive out-of-po...

journal_title：Progress in cardiovascular diseases

authors： Kazi DS,Virani SS

更新日期：2019-01-01 00:00:00

abstract：:Rigorous training remodels the heart of elite endurance athletes to produce the phenotype of the "athlete's heart." This remodeling, which advantages cardiac performance, creates challenges in the diagnosis of cardiac disorders within this population. This is particularly so for right ventricular pathologies because o...

journal_title：Progress in cardiovascular diseases

authors： Sniderman JD,Sado DM,Sniderman AD,McKenna WJ

更新日期：2012-03-01 00:00:00

abstract：:Cardiovascular disease is the leading cause of morbidity and mortality with annual costs of care exceeding 300 billion US dollars. Although screening tools are advocated for many cancers, the use of subclinical disease tests for cardiovascular disease are considered controversial. Health care payers and many governmen...

journal_title：Progress in cardiovascular diseases

authors： Shaw LJ,Raggi P,Berman DS,Callister TQ

更新日期：2003-09-01 00:00:00

abstract：:Left ventricular (LV) ejection fraction (EF) and LV end-systolic volumes are important measures of LV global function. However, in many patients with symptoms of heart failure, these measures are within normal limits. This condition is classified as heart failure with normal ejection fraction (HFNEF). Reduced EF and i...

journal_title：Progress in cardiovascular diseases

authors： Edvardsen T,Helle-Valle T,Smiseth OA

更新日期：2006-11-01 00:00:00

abstract：:Patients with diabetes mellitus have an increased prevalence of hypertension and associated cardiovascular disease (CVD), including coronary and cerebrovascular disease. The risk of an individual of developing CVD is much greater when both diseases coexist and is further magnified by their frequent association with dy...

journal_title：Progress in cardiovascular diseases

authors： Guzmán CB,Sowers JR

更新日期：1999-05-01 00:00:00

abstract：:Two central concepts of human hypertensive disease remain poorly understood: (1) elevated blood pressure as merely one component of an underlying systemic condition, characterized by multiple defects in diverse tissues (eg, "Syndrome X"), and (2) the heterogeneity of hypertension, in which different and even opposite ...

journal_title：Progress in cardiovascular diseases

authors： Resnick L

更新日期：1999-07-01 00:00:00

abstract：:Over the past decade, emerging clinical trial data supported the usefulness of implanted therapeutic cardiac devices (pacemakers and defibrillators) for the treatment of heart failure (HF). Interest has now developed in evaluating the potential of device diagnostics to identify HF patients at risk for clinical events ...

journal_title：Progress in cardiovascular diseases

authors： Whellan DJ,Adams S,Bowerman L

更新日期：2011-09-01 00:00:00

abstract：:The repetitive respiratory events that characterize obstructive sleep apnea (OSA) are each followed by abrupt increases in heart rate and in pulmonary and systemic artery pressure and by sudden decreases in right and left ventricular stroke volume. The changes in systemic pressure may be profound, with patients who ar...

journal_title：Progress in cardiovascular diseases

authors： Weiss JW,Launois SH,Anand A,Garpestad E

更新日期：1999-03-01 00:00:00

abstract：:Positron-emitting myocardial flow radiotracers such as (15)O-water, (13)N-ammonia and (82)Rubidium in conjunction with positron-emission-tomography (PET) are increasingly applied in clinical routine for coronary artery disease (CAD) detection, yielding high diagnostic accuracy, while providing valuable information on ...

journal_title：Progress in cardiovascular diseases

authors： Schindler TH

更新日期：2015-05-01 00:00:00

abstract：:Studies performed in experimental animal models of hypertension as well as in human hypertension have unequivocally shown that reflex cardiovascular control undergoes profound changes with high blood pressure and participates throughout direct and indirect mechanisms at the development and progression of hypertension-...

journal_title：Progress in cardiovascular diseases

authors： Grassi G,Trevano FQ,Seravalle G,Scopelliti F,Mancia G

更新日期：2006-05-01 00:00:00

abstract：:Although "congenital heart disease" incorporates a broad and diverse spectrum of inborn cardiac disorders, one shared feature is the propensity for cardiac arrhythmias, albeit to varying degrees. The magnitude of this issue is underscored by its high prevalence, major impact on morbidity and disability, considerable c...

journal_title：Progress in cardiovascular diseases

authors： Abadir S,Khairy P

更新日期：2011-01-01 00:00:00

abstract：:The use of noninvasive stress cardiac imaging for stratifying risk in patients with known or suspected coronary artery disease is growing as a tool for identification of the subgroup most likely to benefit from the expense and risk of more invasive procedures, including cardiac catheterization and coronary revasculari...

journal_title：Progress in cardiovascular diseases

authors： Brown KA,Rosman DR,Dave RM

更新日期：2000-11-01 00:00:00

abstract：:Dispersion of ventricular repolarization is a now widely used term describing nonhomogeneous recovery of excitability or heterogeneity of ventricular repolarization. It is usually expressed as the difference or the range of various repolarization measurements obtained from a heart. Experimentally, an increased dispers...

journal_title：Progress in cardiovascular diseases

authors： Franz MR,Zabel M

更新日期：2000-03-01 00:00:00

abstract：:Low serum high density lipoprotein cholesterol level (HDL-C) <40 mg/dL in men and <50 mg/dL in women is a significant independent risk factor for cardiovascular disease (CVD), and is often observed in patients with hypertriglyceridemia, obesity, insulin resistance, and diabetes. Patients with marked deficiency of HDL-...

journal_title：Progress in cardiovascular diseases

authors： Schaefer EJ,Anthanont P,Diffenderfer MR,Polisecki E,Asztalos BF

更新日期：2016-01-01 00:00:00

abstract：:Coronary computed tomography angiography (CTA) offers a non-invasive method to detect coronary plaque and stenosis. However, to date, CTA has been most useful as a method of ruling out coronary artery disease (CAD) among patients with low to intermediate pretest probability of significant CAD. The reduced specificity ...

journal_title：Progress in cardiovascular diseases

authors： Hulten E,Ahmadi A,Blankstein R

更新日期：2015-05-01 00:00:00

abstract：:Multimorbidity is the most common chronic health condition in adults and is associated with poor health outcomes. Optimal care for people with multimorbidity requires a person-centred approach that considers goals and preferences, improves quality of life and coordinates care across services. Because care is focused o...

journal_title：Progress in cardiovascular diseases

authors： Holland AE,Lee AL

更新日期：2019-01-01 00:00:00

abstract：:Transcranial Doppler ultrasound allows noninvasive monitoring of the large intracranial vessels. Microembolic signals (MES) have been observed under a variety of circumstances, especially in symptomatic carotid stenosis, high-risk cardiac conditions, and surgical procedures (such as carotid endarterectomy and cardiopu...

journal_title：Progress in cardiovascular diseases

authors： Gorman M

更新日期：2000-09-01 00:00:00

abstract：:Cardiac imaging plays an important role in coronary artery disease (CAD), congestive heart failure (HF) and valvular heart disease (VHD) in the elderly. Imaging defines the structure and function of the cardiac system, refining the understanding of patients' anatomy and physiology and informing a host of clinical care...

journal_title：Progress in cardiovascular diseases

authors： Mehta N,Chokshi NP,Kirkpatrick JN

更新日期：2014-09-01 00:00:00

abstract：:Transcatheter therapy with the MitraClip system (Abbott Structural, Menlo Park, CA) is the most commonly used transcatheter therapy for patients with tricuspid regurgitation, with over 1000 cases performed worldwide. The procedure is an off-label approach that requires meticulous attention to anatomical features obtai...

journal_title：Progress in cardiovascular diseases

authors： Sorajja P,Cavalcante JL,Gossl M,Bae R

更新日期：2019-01-01 00:00:00

abstract：:With the approval of alteplase (tPA) therapy for stroke, it is likely that combination therapy with tPA to restore blood flow, and agents like glutamate receptor antagonists to halt or reverse the cascade of neuronal damage, will dominate the future of stroke care. The authors describe events and potential targets of ...

journal_title：Progress in cardiovascular diseases

authors： Small DL,Morley P,Buchan AM

更新日期：1999-11-01 00:00:00

abstract：:There is a strong evidence that more marked lowering of low-density lipoprotein cholesterol (LDL-C) leads to progressively lower risk of cardiovascular disease (CVD) events. The evidence on validity of this hypothesis comes from epidemiological, genetic and clinical studies. The hypothesis "the lower the better" has b...

journal_title：Progress in cardiovascular diseases

authors： Cybulska B,Kłosiewicz-Latoszek L,Penson PE,Nabavi SM,Lavie CJ,Banach M,International Lipid Expert Panel (ILEP).

更新日期：2020-12-28 00:00:00

abstract：:The recent advent of an entirely subcutaneous implantable defibrillator (ICD) has provided a relevant contribution to the debate concerning the use of ICD therapy in patients at high risk for death. Although conventional transvenous ICDs have proven very effective during the past 23 years, they still appear to be limi...

journal_title：Progress in cardiovascular diseases

authors： Lupo PP,Pelissero G,Ali H,Sanghera R,Cappato R

更新日期：2012-05-01 00:00:00